Literature DB >> 17806109

Characteristics of Hylamer polyethylene particles isolated from peri-prosthetic tissues of failed cemented total hip arthroplasties.

Kentaro Iwakiri1, Hiroyoshi Iwaki, Akio Kobayashi, Yukihide Minoda, Hiroshi Kagiyama, Yoshinori Kadoya, Kunio Takaoka.   

Abstract

Polyethylene wear particles are one of the most important factors affecting the results of total hip arthroplasty. Hylamer, a highly crystalized ultra-high-molecular-weight polyethylene, has been used in total hip arthroplasty for wear reduction, but has exhibited high wear rate and excessive osteolysis. The aim of the present study was to examine Hylamer wear particles in peri-prosthetic tissues with osteolysis obtained from two cases of failed cemented total hip arthroplasty at 8 and 6 years after operation. Polyethylene particles were isolated, and examined using a scanning electron microscope and image analyzer. Total numbers of Hylamer polyethylene particles in the two cases were 5.6 x 10(9) and 8.0 x 10(9) g(-1). Particle sizes (in equivalent circle diameter) for the two cases were 1.07 +/- 0.06 microm and 1.16 +/- 0.05 microm, and particle shapes (roundness) were 3.05 +/- 0.22 and 3.76 +/- 0.28. The Hylamer polyethylene particles were larger in size and more elongated and their number was larger, compared with the corresponding reported values for particles generated from conventional polyethylene. This increase in particle number and elongation may lead to early osteolysis in total hip arthroplasty with Hylamer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17806109     DOI: 10.1002/jbm.b.30924

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  1 in total

1.  In vivo wear particles of remelted highly crosslinked polyethylene after total hip arthroplasty: report of four cases.

Authors:  Kanako Hata; Yukihide Minoda; Mitsuhiko Ikebuchi; Shigekazu Mizokawa; Yoichi Ohta; Nobuyuki Miyazaki; Yusuke Miyake; Hiroaki Nakamura
Journal:  J Mater Sci Mater Med       Date:  2015-02-25       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.